Anticancer activities of sesewanua leaf extracts (Clerodendrum fragrans (vent.) willd) against a549 lung cancer cell

Abstract

BACKGROUND: Cancer is one of the leading causes of non-communicable diseases in the world, with about 10 million deaths worldwide in 2020. Lung cancer was the most common type of cancer and the highest cause of death. Therapy for lung cancer can be either conventional therapy or molecular targeted therapy that has many limitations. AIM: It is, therefore, important to explore new sources of anticancer activity, including those from plants. One plant that is thought to have anticancer activity is Sesewanua (Clerodendrum fragrans [Vent.] Willd. Syn. Clerodendrum chinense [Osbeck] Mabb., Family Lamiaceae). METHODS: This research is a laboratory experiment. The sample used is the C. fragrans leaves obtained in Malalayang I Timur Village, Malalayang District, Manado City, North Sulawesi Province, while the subjects in this study were A549 lung cancer cells from Cell-Culture Laboratory, Faculty of Pharmacy, Universitas Padjadjaran Bandung. Anticancer activity test was using the MTT tetrazolium assay method. Data in the form of a percentage (%) inhibition of cell proliferation, then determined the value the concentration of 50% proliferation inhibition (IC50) using a computer program online. RESULTS: The results showed that ethanol extract, hexane fraction, ethyl acetate fraction, and water-soluble fraction of C. fragrans had anticancer activity on A549 lung cancer cells. The smallest IC50 value is indicated by ethyl acetate fraction (191, 165 ppm), which is categorized as moderately active.